Contacts
Adrian Toutoungi

Adrian Toutoungi

Partner

Read More
josef fuss

Josef Fuss

Partner

Read More
Contacts
Adrian Toutoungi

Adrian Toutoungi

Partner

Read More
josef fuss

Josef Fuss

Partner

Read More

4 September 2020

Adrian Toutoungi, Josef Fuss and Matt Caskie discuss how biotech has managed its finances during the pandemic

  • QUICK READ

The COVID-19 pandemic has had huge knock-on effects on economies around the world.

In this article for European Pharmaceutical Review, we explore how the novel coronavirus has hit the life sciences and biotech investment sector and how they see investors behaving as the lockdown and pandemic eases and develops over the next 24 months.

Read the full article first published in European Pharmaceutical Review in Issue #4 2020 on 25 August 2020.

Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe